Leaflet IXIARO 6mcg / 0.5ml intramuscular injection suspension

Product code:
W54590001
Quantity:
1
Indicated for:
prevention of Japanese encephalitis
Route of administration:
intramuscular
ATC
J07BA02 — Antiinfectives for systemic use | Viral vaccines | Encephalitis vaccines

Precautions:

Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Additional monitoring

This medicine is subject to additional monitoring.

Refrigerated storage

Store in the refrigerator as instructed in the leaflet.

Protect from light

Store protected from light.

The Japanese encephalitis vaccine (inactivated, adsorbed) is used to prevent Japanese encephalitis, a severe viral disease transmitted by the bite of infected Culex mosquitoes. The Japanese encephalitis virus is endemic in many parts of Asia and the Pacific, and the disease can cause severe brain inflammation, with risks of death or long-term neurological complications.

The vaccine contains inactivated viruses and is administered intramuscularly, usually in two doses, 28 days apart. It is recommended for individuals traveling to or living in endemic areas, as well as those working in laboratories with potential exposure to the virus.

Common side effects include pain at the injection site, mild fever, headache, and fatigue. In rare cases, severe allergic reactions may occur.

The Japanese encephalitis vaccine (inactivated, adsorbed) is an essential measure for protecting against this potentially fatal disease, helping to reduce the risk of outbreaks and safeguard public health.

General data about IXIARO 6mcg / 0.5ml

Substance:
Japanese encephalitis vaccine (inactive, adsorbed)
Date of latest medicines list:
01-07-2013
Product code:
W54590001
Concentration:
6mcg / 0.5ml
Pharmaceutical form:
intramuscular injection suspension
Quantity:
1
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.